NDI Articles:

Senator Durbin & the FDA Viciously Attack Dietary Supplements

Under the cover of the July 4th holiday, Senator Richard Durbin (D-Illinois) and the FDA launched an unprecedented and coordinated assault on the dietary supplement industry – in essence a direct attack on consumers who rely on dietary supplements to support their health. Without a massive consumer protest of this abhorrent abuse of regulatory power, consumers will be denied access to many dietary supplements they currently take. Furthermore, the cost of dietary supplements will skyrocket due to the unnecessary regulatory burden imposed upon supplement companies, ongoing legal wars, and reduced competition in the industry. While there are many political forces in play, it is clear that one of the main goals of this attack is to allow the pharmaceutical companies to take over the dietary supplement industry. It is very difficult for the typical consumer of dietary supplements to understand why extreme harassment of the dietary supplement industry is taking place. Such attacks are typically launched under the false cover of “consumer safety,” a pretense that plays well for sound bites and is without merit. Thus, it is of great importance to explain this current attack in the historical and political context in which it is occurring. It is of even greater importance that every consumer of dietary supplements takes immediate action to preserve their access to quality, cost effective dietary supplements. At the end of this article is a Take Action Now section that explains the steps you should take today. /images/uploads/flag_web.gif

Read More:  FDA, health freedom, NDI, new dietary ingedient, S.1310, Senator Durbin

The FDA’s Scheme to Reclassify Nutrients as Drugs

The FDA and Senator Durbin’s latest attack against the dietary supplement industry should leave consumers for natural health options at affordable prices up in arms. This attack will target some of the most popular and effective dietary supplements, removing them from the free market and placing them under control of large pharmaceutical companies. This move will drastically drive up the price of dietary supplements while severely limiting access to extremely safe and effective nutrients. For example, the GlaxoSmithKline prescription drug version of DHA fish oil (at a therapeutic dose) sells for $189 a month, whereas the equivalent, therapeutic amount of molecularly-distilled DHA sells for $35 a month in the dietary supplement marketplace. Proven to lower triglyceride levels at therapeutic amounts, it is not surprising that DHA is one of the first nutrients the FDA plans to go after. Other powerful nutrients, such as curcumin and resveratrol, are soon to follow.

Read More:  dietary supplement industry, Fabricant, FDA, investigational new drug application, NDI

FDA Propaganda Attempts to Destroy the Dietary Supplement Industry

It is not surprising that FDA Commissioner Margaret Hamburg would use blatant and deceptive propaganda to attack the dietary supplement industry. As a self-proclaimed “zealot for the advancement of regulatory science,” Hamburg would like the consumer public to believe the earth is flat—and that dietary supplements cannot prevent and help treat disease. She is well-educated in science, especially neuropharmacology and the new genomic science, thus it poses a dilemma for her when study after study demonstrates the power of dietary supplement ingredients. These studies show that dietary supplement ingredients influence the human genome in ways that prevent disease as well as offer practical solutions to help treat most common, age-related diseases that afflict millions of Americans. Such diseases include type 2 diabetes, cardiovascular disease, and many resistant forms of cancer.

Read More:  Big Safety Lie, FDA, Hamburg, NDI, propaganda

FDA To Supplements: Drop Dead

The following article, FDA to Supplements: Drop Dead, is written by attorney Jonathan Emord, a leading constitutional and health freedom attorney in this country. He has defeated the FDA in federal court a remarkable eight times. This article first appeared August 22, 2011 on the NewsWithViews website. He provides insightful legal analysis, the history of the problem, and even explains how supplement industry trade groups CRN and NPA have inappropriately sent the industry on an improper course of action that has culminated in the recent NDI attack. Here is what Emord has to say:

Read More:  dietary supplements, Emord, FDA, NDI